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Hepatic allograft transplantation has become an accepted form of therapy for 
treatment of a variety of Ijfe-threatening liver diseases [1-4]. The indicacions for 
this procedure range from end-stage liver failure, due to a variety of causes, to 
patients with inborn errors in metabolism and hepatic malignancy. The success 
of this procedure has been well documented. With the advent of cydosporine 
immunosuppression. 60-70% ~-yr survival rates are being achieved [1]. Re;ec-
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tion continues to be a major cause of graft dysfunction. in spite of tech'lological 
and immunosuppressive advances (1,4]. 
While little is known about the immunobiology of hepatic rejection, several 
observations point out possible differences from other allograft rejection models. 
The ability to transplant cadaveric liven in spite of a positive lymphocytotoxicity 
cross-match and across ABO incompatibilities highlight possible differences in 
allorecognition [5,6]. Whether this reflects the unique anatomic architecture of 
the liver, or whether there are differences in the expression of alloantigens. is 
not known. Several studies have demonsuated disparity of expression of class I 
and class II MHC antigens on normal liver vasculature when compared to other 
vascularized organs [7.B]. 
While most current models of aIlorecognition and subsequent rejection assign 
T lymphocytes a central role [9]. little is known regarding the function of these 
cells or their contribution to the severity of graft rejection. Immunohistochemical 
staining of organ transplant tissues with monospecific cell surface marker anti-
bodies has given conflicting data on the CD4 and CDB marken l of infiltrating 
T cells [11-14]. These studies have other limitations: (i) inability to correlate 
cell surface markers with functional characteristics of the ce[s in question. and 
(ii) presence of "irrelevant" mononuclear cell infiltrates in the absence of clinical 
rejection within the allograft (15.16). Several models have therefore been ad-
vanced to study the functional characteristics of infiltrating graft cells and their 
role in rejection. In vitro functional assays of enzymarically isolated lymphocytes 
from rejected organs have demonstrated allospecificity (17]. The sponge-allograft 
model has been employed to study the kinetics of graft infiltration (lB.19J. Recent 
advances in T-cell culture technology have enabled the propagation and expansion 
of activated T cells from allograft biopsies. Kim et aI. have shown that cloned 
noncytotoxic T -cell lines from mouse skin allografts could mediate rejection when 
reinjected into naive animals (20). Both Moreau et aI. (21). and Mayer et al. 
[22]. have described isolation of functionally active allospecific human T -cells 
lines propagated from either percutaneous biopsies or rejected renal grafts. We 
have recently described the allospecificity of T cells grown from serial enda-
myoc!Udiai biopsies from heart allograft recipients. and demonsttated both class 
I and class II HLA recognition (23). 
We are interested in undentanding the mechanisms of allorecognition and 
hc:patic rejection. Because immunologic monitoring of peripheral blood has 1;-
itUions in these patients (24), we have routinely obtained liver core biopsies 
during an episode of hepatic allograft dysfunction for histologic confirmaticn of 
cellular infiltration. Utilizing T-cell culture techniques. we report the functional 
character~zation of expanded T cells from these biopsies. 
MATERIALS AND METHODS 
SDllrn """mal. Samples of hepatic allografts were obtained from clinical material 
taken from percutaneous liver biopsies. intraoperative liver biopsies. or allograft 
hepatectomies. The patient profile is shown in Table 1. All transplant recipients 
were placed on post-operative intravenous cyc1osporine A and steroids, as main-
tenance immunosuppression. Indicanons for sampling were derangements in liver 
function tests and bile composition via T-tube drainage from the allograft [2H 
IThe nomenclarure CD3. CD4. and CDS refer (0 n. T4. and TB. respecrivel7. IoCcordil18 ro rhe 
1984 ~po" by the Commirwc on Hwnaa Leucocyre DifTerenriuion Anri&enl: IUISIWHO No-
mendaru~ Subcommiuee (10). 
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TABLEJ Patient and allograft profile 
Parienc . " l..ivn 
number A&e Sex Primary d;'posis biopsy 
I 
2 
3 
<4 
~ 
6 
7 
8 
9 
10 
11 
12 
13 
1<4 
19 M 
<4<4 f 
~ f 
27 M 
<42 N 
7 F 
<48 f 
<42 N 
36 f 
17 N 
17 F 
15 N 
<43 f 
9 N 
cIuoaic bepIIids 
~
bepIIic arciDaaIa 
Carob .. , Diteae 
~
biIiIry aaaia 
....., biIiuy cirrhosis 
poll bepecicic cirrhosia 
ar .... - cirrboaia 
WiIIoD', Diteae h',..... ......... 
ICIeroaiaI cboIenpris 
primary biIiuy cirrbosia 
AIIIiIIea Syadrome 
l.78 
2.16A 
3.32A 
U2A 
5.3008 
6.73A 
TK~A 
8.9A 
8.BA 
9.9A 
9.118 
9.398 
1MK~9B 
II.M 
12.3A 
BK~A 
13.288 
14.3A 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
DO 
yes 
AU material was caken in • sterile manner for propagation of infiltrating cells and 
for histologic evaluation. 
.... His"". Samples seat for histolog were sectioned and stained with (i) he-
matOXylin and eosin, (ii) recicuIin, aocl in several instances (iii) immunohisto-
chemical stainsI~K ana-T ceD.1Ilrl-8 cell. and ana·DR. These slides were then 
evalualed in a blind manner by one of us (J.D.) using previously defined criteria 
for liver rejectioa [25-28]. 
Plltul ails. Lymphocytes were obc:ained either by mechanical disruption of donor 
spleens, obcained during ocpo procurement, or from periphenl blood' from 
normal healthy adult volunteers. Cells were isolated by centtifuption over • 
FacoD-Hypaque sradienc (sp gr 1.077) (Picoll.Paque, Phannacia. Pisc:auway, NJ) 
and washed sevcnl times with Hank's Balanced Salt Solution (BacBlSC01T, 
FISIceviIle, R1). Vaability was determined with trypan blue and the cell aliquou 
were frozen in 20% hwnan AD serum aod 20% dimethyl sulfoxide. and stOred 
in liquid nirrogea. EBV -umsformed lymphoblasroid ceD lines (LCL) were pre-
pared from doGor spleaoc:yrp usiaa Epstein-Barr virus and cyc1osporine A [29], 
PHA-uansformcd lymphoblast culaues were prepared by incubating lympho-
cytes with phytobemaglutin-M (PHA) (DIFCO. Decroit, MI) for" days prior 
to use. 
Gtllmlli .. D11~botIk tltiums tm-1iM- u.pks. Percutaneous aod iocnoper-
acne core liver biopsies were divided into sevenI smaller fnsmeau, senenIly 
4-12 in nUIDbu. AUosnfc hep.lectamy samples were similarly seccioDed bur 
die yield ·wu .ubaaaa.lly grearer aocl • coal of 96 ffl&lllelltl were proceued. 
for purposes of chis paper. aIl1iver samples wiD be designaced as ""biopsy." AU 
fnpleGtI were individually pLaced into 100 1'1 tissue culture medium (TCM) 
supplemented with 100 '" recombiNnt 1L-2 (Sandoz Pharnulceuticals, Basel) 
(final dilution 1:10,000) in 96-weD microculture plates (COSTAll. Cambridge, 
"D1:f;~KrIl:IK ~lK~~>K;D"K 
.. r_ 
.' 
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MA). TCM consisted of RPMI-I640 (B&B/SCOm. supplemented with 10% 
normal human AB serum, 4 mM L-gluwnine, 24 mM HEPES buffer, and 60 
p.g/ml of gentamycin sulfate (GIBCO, Chagrin Falls, OH). . 
Liver sample cultures were incubated at 37°C in a humidified 5% CO2 atmo-
sphere. After 3-4 days culture, supernatants were replenished with fresh TCM 
supplemented with recombinant 11.-2. The cultures were observed daily on an 
inverted stage microscope for cellular outgrowth. When growth was observed, 
the contents of the wells were pooled and transferred into 24 well culture plates 
(COSTAR) and again supplemented with IL-2 and TCM. After approximately 2 
weeks, sufficient cells were obtained for functional and phenotypic studies as 
well as for further propagation. 
PrimtJ Iymphocytt Itslin, (PLT). The PLT activity of lymphocyte cultures grown 
from liver samples was measured in 3-day proliferation assays, as previously 
described for alloreactive T-cell clones [30,3 I]. Prior to testing, the lymphocyte 
cultures had not received IL-2 for 3 days. This was necessary to reduce back-
ground proliferation of these cultured cells. In each PLT assay, 5 x 103 cultured 
cells were incubated for 72 hI' with 10% AB serum, IL-2, or 5 X 1<r irradiated 
stimulators (2000R) in 96-well round bottom microculture plates with TCM in 
a final volume of 200 pJ. During the final 20 hI' of incubation, each culture was 
pulsed with llLCi of3H-thymidine (specific activity, 20 mCilmmol, New England 
Nuclear Products, Boston, MA). The cultures were harvested with a multiple 
sample harvester (Sutron, Inc, Sterling, V A) and uptake determined by liquid 
scintillation counting (LKB, Gaithersburg, MD). 
PLT inhibilion with monoclonlll anliboJies (MoA.b). Inhibition of proliferation of 
• • bulk cultured biopsy T cells to irradiated donor lymphocytes, by monoclonal 
anci-class I and anti-class II antibodies, was accomplished according to previously 
described methods [32]. Briefly, the same number of scimulator and responder 
cells as for PLT, in 100 pJ TCM, were coincubated with 100 pJ of various MoAbs. 
The following MoAbs, with their corresponding HLA molecular specificity, were 
used: SG 15 7 (anti-DR) and SG465 (broad anti-class II) (5. Goyen and J. Silver 
[33]); L243 (anti-DR) and Leu 10 (anci-DQwl + w3) (Becton Dickinson, Moun-
tain View, CA (34-36]); and PA2.6 (anti-HLA-A,B,C) (P. Parham (37,38]). The 
PLT activity was measured in a 72-hr assay as described above. 
Ctll meJialtJ cyloloxicity (CML). The CML activity of lymphocyte cultures grown 
from liver samples was measured in 4-hr 'ICr release assays, according to previous 
descriptions for alloreactive T-cell clones (31] with slight modifications as noted. 
Briefly, targets were 4-day PHA stimulated spleen cells (class I targets) or EBV-
transformed spleen cells (class I and II targets) from the donor or other HLA-
typed panel cells (LCL). An effecror:wget ratio of 10: 1 was used to measure 
release of labeled chromium from 2 x 103 labeled target cells. A measured 
aliquot of supernatant was mixed with a high-d'6ciency aqueous compatible scin-
tillation counting mixture (READY-SOLV HPIb, Beckman Instruments, Fuller-
ton, CA) and coueued in a liquid scintillarion counter. The percentage of CML 
expressed was calculared from a formula which represents a ratio of experimental 
to total <determined by lriton-X release) "Cr release (subtracting spontaneous 
release) [32]. 
CtU sur/au phmoIJPi( "",,/ysis. Lymphocytes grown from liver samples were tested 
for various T -<ell differentiation antigens using a modification of the avidin-biotin-
immunoperoxidase technique (39]. The following differentiation markers were 
.. 
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. analyzed: CD3 (pan-T cell), CD4 ("helper/inducer T cell"), and COS ("cyto-
toxidsuppressor T cell") (OKT series purchased from Orrho Diagnostics, Rantan, 
N); Leu series purchased from Becton Dickinson. Sunnyvale. CAl. In addition. 
anti-DR staining was similarly done using a monoclonal anti-HLA-DR (Becton 
Dickinson). Briefly, cytocentrifuge smears were prepared. using 2.5 X 1 ()4 ceIWslide, 
and fixed in acetone immediately after preparation. A total of 200-400 cells were 
enumerated. 
HLA phmotyping. Peripheral blood lymphocytes, donor spleen cells, and Iym-
phoblastoid cell lines (LCL) were typed for HLA A, and B antigens by the standard 
NIH microlymphocytotoxicity technique. Serologic typing for HLA DR was done 
by prolonged incubation microlymphocytotoxicity test using enriched B-cell 
preparations obtained following carbonyl-iron treatment and Ficoll-H ypaque sed-
imentation after rosetting with neuraminidase treated sheep red cells. 
Statistical analysis. Cultured lymphocytes were defined as reactive towards a 
given stimulator cell in proliferation assays when the tOtal incorporated sH_ 
thymidine COunt ± 2 SO was greater than background counts (i.e., counts with 
cultured lymphocytes with 10% AB serum alone plus irradiated stimulator cells 
with 10% AB serum alone) ± 2 SO. Analysis of statistical significance was done 
using the Chi square test. 
RESULTS 
Patient/Sample Profile 
Lymphocytes were grown from 18 biopsies obtained from 14 liver transplant 
patients. Table 1 summarizes the salient features of these patients including age, 
sex, primary diagnosis at the time of transplantation, the post-transplant day of 
the biopsy, and the current status of the allograft. In this paper, each liver biopsy 
(LB) culture is referred to by a unique number which identifies the patient and 
the post-transplant day when the biopsy was obtained. In addition, the letters A 
and B designate the first and second allografts, respectively. For example, LB 1. 7 B 
was obtained from patient 1 on day 7 post-transplant from the second allograft 
~d LB2.16A was obtained from patient 2 on day 16 post-transplant from the 
first liver transplant. This representative population of transplant patients in-
cluded patients with end-stage liver failure due to a variety of causes as well as 
patients with inborn errors of metabolism and hepatic malignancy (Table 1). 
Biopsies were obtained from 11 first transplants and five second transplants, 
including ~o patients (9 and 13), who provided specimens from both first and 
second allografts. The interval from transplantation to biopsy ranged from 3 days 
to 330 days, with a median of 14 days post-transplant. 
Generation and Expansion of Amvated T Lymphocytes 
from Liver Biopsies 
Biopsies obtained from hepatic allografts were incubated in viero, in the presence 
of recombinant human 11.,2, but without the addition of irradiated feeder cells. 
After 2-3 days, an outgrowth of mononuclear cells was seen (FIgUre 1). The 
cultureS were supplemented at 2-3 day intervals with 11.,2 and transferred into 
larger wells. Expansion was continued until confluence was obtained. generally 
within 10-14 days following initial biopsy. Sufficient number of cells (5 x 101-1 
X 10') were then obtained for functional assays and phenotypic analysis. 
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FIGURE 1 In vitro propagation of lymphocytes from a liver biopsy culture. This is a 
400 X magnification <original magnification) taken with an inverted stage microscope 4 
days after expansion in tissue culture medium supplemented with IL-2. The dark area in 
the left corner is the liver biopsy tissue. 
Phenotype analysis of biopsy-grown mononu<:lear cells showed a predomi-
nance of CD3 positive T lymphocytes. many of which also expressed DR antigens 
(an indication of activation [40]). Biopsy cultured lymphocytes were typed phe-
notypically berween 2 and 4 weeks following sampling. Table 2 lists representative 
results which also demonstrate a mixture of CD4 and CDS positive cells in most 
cultures. Among seven lymphocyte cultures tested, there seemed to be an overall 
trend towards CD4 predominance. although statistical significance could not be 
established, possibly because of small sample size. In rwo patients (S and 10), 
who had undergone a percutaneous liver biopsy, subsequent allograft hepatec-
tomy was required for unremitting rejection shortly thereafter. Cells from these 
rejected livers, extracted by mechanical disruption followed by Ficoll-Hypaque 
purification and then directly analyzed, showed very similar phenotype profiles 
co cells grown from the biopsies (Table 2). 
Allospecificity of Infiltrating Allograft T Cells in 
Secondary Proliferation 
The alloreacavity of biopsy-grown lymphocytes was determined in secondary 
proliferation assays (PLT). Table 3 shows the proliferative responses of biopsy-
cultured lymphocytes to irradiated spleen cells from the transplant donor and 
also to exogenous IL-2 in 3-day assays. 
All cultured lymphocytes exhibited low spontaneous thymidine incorporation 
and high proliferative responses to IL-2 suggesting the presence of activated T 
cells with receptors for 11-2 (Table 3). The majority of expanded lymphocytes 
also showed strong proliferative responses to original donor lymphocytes. How-
ever, five biopsy-grown lymphocyte cultures expressed little or no PLT reactivity 
towards donor cells (LB2.16A, LB4.12A, LBl1.3A, LB12.3A, and LB14.30A>. 
When the phenotypes of these cultured T cells were correlated with donor-
specific proliferation, no correlation berween a predominance of CDS bearing 
cells ("suppressor/cytotoxic" subset) and a lack of proliferation could be found. 
We next compared the cause of graft dysfunction with the ability of the cultured 
lymphocytes to proliferate against donor cells. A statistically significant correla-
188 
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TABLE 2 Phenotypic analysis of lymphocytes 
: . ..;, 
Puieol Surface Liver 
nwnbel' marker biops,. 
8 C03 86 
CD4 37 
CDS S~ 
Oil NO 
10 C03 94 
CD4 P~ 
CDS 60 
Oil ~U 
2 C03 94 
CD4 62 
CDS 2" 
Oil S~ 
C03 93 
CD4 ~U 
CDS 27 
Dil 4~ 
1" C03 86 CD4 66 
CDS 9 
Oil S~ 
~I bulk CIIIauoed ceIIL 
'Bulk ftII'8CIIeCI cells '- .... p.u_, . 
J. J. Fuag et al. 
91 
31 
57 
NO 
NO 
NO 
NO 
NO 
NO 
NO 
NO 
NO 
NO 
NO 
NO 
NO 
tion of low donor induced proliferarion with ischemic hepatic allograft dysfunc-
tion was noted, usina the Chi square teSt for 2 X 2 coatigency abies. p < 0.01. 
Of the five cultures with little PLT reactivity. ischemic iajUI'J was the cause of 
dysfuactioa in duee.lo me remainder of cultures that demoastnted ItI'ODI donor 
stimulated proliferation, rejectioa was the cause of snft dysfuoctioo ia all but 
ODe. 
Biopsy-growa lymphocyteS were also teSted for PLT specificity qaiast a panel 
of uarelaced cells selected co sbare liLA antigens with the oripaal ttaasplant 
donor. 10 mao, iascaaca. it was possible to determioe the allospecificicy of these 
aDs. Table" I1IIIUIWiza the appueat PLT specificity for those cultured lym-
phocyte lines that proliferaled spiDle donor HLA specificities. Three biopsies 
hid PLT specilicities limited to class I antigens, seven were class II specific. 
wbereu three biopsies appeared to concaia cells that recopize both class J and 
II donor an ..... Ilepraeawive examples of resula of the PLT aaaI,sis on 
biopsy-growa lymphocytes from three par.ieoa are described below. 
P.,iftI; 3. Pacieae 3. who was HLA typed A2",26; B3S,w41; DIU.S; received. 
lMruansplaatfromadooorwbo typed asA~lIOU; B3S,w60; Dllw6,7. On post-
tnasplaat day 32, the paieat developed elevaced liver enzymes while uluasound 
sNdies indicated aormal aUosnft architecture. The hiltolosy of. percutaneOUS 
/' 
TA
B
LE
 3
 
Pr
ol
ife
ra
tiv
e 
re
sp
on
se
s 
vs
. 
hi
sto
lo
gy
 
Li
ve
r 
O
a,
s 
in 
bi
oP
l, 
cu
lru
re
 
8a
cl
ca
ro
un
d 
1.
7A
 
12
 
4'
2 
%
 6
2 
3.
ll
A
 
14
 
2,
09
7 
%
 1
,6
08
 
5.
30
08
 
12
 
82
5 
%
 9
2 
6.
73
A
 
10
 
30
3 
%
 6
5 
7.
M
 
14
 
85
8 
%
 1
14
 
8.
9A
 
9 
70
8 
%
 6
0 
8.
13
A
 
7 
91
6 
±
 
19
1 
9.
9A
 
12
 
22
2 
±
 2
3 
9.
11
8 
12
 
2.
21
0 
±
 
33
5 
9.
39
8 
8 
1.
21
1 
±
 
15
2 
10
.'9
8 
4 
61
4 
±
 
19
4 
13
.M
 
10
 
93
9 
±
 
75
 
13
.2
88
 
7 
4,
44
7 
±
 
19
4 
2.
16
A
 
21
 
25
7 
::
 3
5 
4.
I2
A
 
10
 
41
1 
±
 
11
2 
Il
.3
A
 
15
 
1.
11
8 
±
 
11
 
12
.3
A
 
18
 
63
1 
%
 
14
5 
14
.3
0A
 
21
 
18
7 
%
 ,
 
'D
oo
ot
 "
D
 _
 
an
ila
bl
e.
 m
u
im
um
 .r
im
ul
ar
io
a 
w
ith
 .
-
d
 ce
IL
 
"
 
,
 
,
 
Pr
ol
i(e
rat
ive
 re
sp
on
se
s 
(C
PM
 %
 S
.D
.) 
Ex
o,
en
ou
. 1
1..-
2 
19
,"
1 
%
 
1,
'1
6 
13
,4
13
 %
 
1,
39
' 
8,
61
4 
%
 3
6'
 
15
.8
70
 %
 9
08
 
11
.8
67
 %
 1
.4
'1
 
2.
55
6 
±
 5
0 
15
.2
15
 ±
 
71
 
7.
73
0 
±
 
30
6 
34
.6
78
 ±
 
1.
55
6 
9.
29
9 
±
 9
3 
30
,7
13
 ±
 
1.
20
9 
14
.9
81
 ±
 
88
4 
55
03
95
 ±
 
1.
69
4 
10
,1
89
 :
: 
74
4 
•
 
8.
53
6 
±
 
17
0 
24
.4
20
 ±
 6
06
 
25
.7
5'
 ±
 
3.
14
9 
9.
77
' 
±
 
15
 
Ca
us
e 
o
r 
p
t
 
D
on
or
 S
tim
ul
ate
d 
dy
.(u
nc
tio
n 
27
,4
72
 %
 2
,7
41
 
m
o
de
ra
te
 re
jec
tio
n 
17
.1
20
 ±
 
1.
11
9"
 
m
ild
 r
eje
cti
on
 
9.
40
4 
%
 
1.
46
6 
m
ild
 r
eje
cti
on
 
16
.2
23
 ±
 8
27
-
se
v
er
e 
re
jec
tio
n 
9.
H
4 
%
 
1.
75
7 
m
o
de
ra
te
 r
eje
cti
on
 
4.
00
8 
±
 
38
0 
se
v
er
e 
re
jec
tio
n 
27
.7
38
 ±
 
1.
98
9 
m
o
de
ra
te
 re
jec
tio
n 
1.
89
41
 ±
 9
'9
 
se
v
er
e 
re
 jec
rio
n 
22
.8
96
 ±
 
1.9
00
 
m
o
de
ra
te
 re
jec
tio
n 
21
.'4
7 
±
 1
.'4
4-
se
v
er
e 
re
jec
tio
n 
18
,0
67
 ±
 
91
1 
se
v
er
e 
re
jec
tio
n 
8,
44
8 
±
 
11
5 
ea
rly
 re
jec
tio
n?
 
12
5.
29
4 
±
 
1.
97
2 
isc
he
m
ic
 in
jur
y 
2.
77
4 
::
 
1.
11
9"
 
isc
he
m
ic
 in
jur
y 
72
8 
±
 
11
7 
m
ild
 r
eje
cti
on
 
2.
69
0 
±
 
1.
45
4 
isc
he
m
ic
 in
jur
y 
86
, ±
 
44
2 
ye
as
e 
in
fe
ct
io
n 
'
93
 ±
 
64
 
m
o
de
ra
te
 re
jec
tio
n 
- ~ /'
 
-_ ... _ .•._-----
liver biopsy showed subintimal lymphocytic infiltrates in the portal triads con-
sistent with mild rejection. 
.. The PLT specificity of LB3.32A was associated with DRw6 and DR7 antigens; 
all six positive stimuJaror ceDs bore either anti&en specificity whereas all of the 
(our neprive ceDs lacked these class II antigens (Fagure 2). 
FIGUllE 2 PLT specificiry of lB3.32A. Tritiated thymidine uptake was determined in 
~y proliferation usay •. HLA ..... of the panel cells are listed, chose shared with 
the original donor are unclerliocd. The beckpouad counl wilh 10% human AB serum 
was 2097 :: 1608 (1 SD). 
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Patient 8. Patient S, was HLA Iyped as A24,25; BS.w62; DR1,4 and had received 
a liver from a donor with HLA antigens A3.24; B1S.3S; DRS,-. The patient 
developed elevated liver funaion tests 9 days post-transplant. A percutaneous 
liver biopsy showed a lymphocytic portal infiltration pattern consistent with 
moderate to severe rejection. Lymphocytes grown from biopsy LBS.9A showed 
PLT specificity associated with HLA B1S and B3S, both class I antigens. Seven 
out of eight positive stimulator cells had either the B1S or B35 antigen while 
only one of seven negative stimulator cells bore either antigen. In addition, only 
three of seven stimulator cells cyped as DRS were positive in this PLT assay, 
indicating weak reactivity to this specificity (Table S). 
In spite of aggressive immunosuppression the patient had continued clinical 
deterioration requiring allograft hepateaomy followed by retransplantation 4 
days later. Fragments of the first donor liver (LBS.13A) were incubated under 
conditions similar to the initial biopsy and the expanded cells were tested .pnst 
the same panel of cells. Histolosically, the portal infiltrate appeared less extensive 
but a residium of lymphocyteS and macrophages was noted, consistent with re-
solving rejeaion. As shown in Table 5. specificities to which these cells reacted 
towards were B1S and DRS. AU four B1S positive stimulator cells and all seven 
DR5 positive panel cells stimulated T cells expanded from this biopsy, whereas 
five of five B IS and DR5 Deprive panel cells failed to do so. Thus it appears 
that within the interim. acquisition of DR5 reactivity appeared. 
Pa,i,,,, 9. Patient 9. typed as Al,-; B3S,w62; DR5,w6; received a first allograft 
from an A26.11; B1S.w41; DR2,5 donor. Following initial satisfactory function. 
elevation of the serum bilirubin 5 days post-transplant necessitated a percutaneous 
liver biopsy for diagnosis. Histologically. there was no portal infiltrate and no 
- Jymphocytes could be grown from the biopsy. Four days later, however. because 
of increasing liver dysfunction, an allograft hepateaomy was performed. At this 
time. histologically there was moderate portal tract infiltrates with biliary epi-
TABLE 5 P.LT reactivity of liver biopsies from patient #S 
HLA cype 
1B 8.9A 1B 8.BA 
It. 'A 8 B DR DR (CPM) (CPM) 
3 24 18 3) ) 4,00S- 27,n8 
29 24 44 3) ) 7 8,022 1&!! 
2 31 18 60 4 1,220 2),821 
1 2 18 27 4 6 ZA2! 7,n8 
2 )0 3) 7 4,600 NO 
26 30 49 3) 6 8 z..m NO 
26 11 18 41 ) 2 4,879 14,011 
2 3 62 3) ) 720 l.llil 
2 8 44 ) 3 1.034 4,649 
1 30 13 )1 ) 2 123 8.0)0 
3 26 14 )1 ) 1 387 6,640 
2 3 44 62 4 402 1.))3 
11 24 60 2 14) 2,003 
2 11 7 44 2 7 3)) 3,008 
31 13 60 4 7 NO 1.267 
2 24 7 49 2 4 NO 809 
'POlitRoe "int....,. are .....xrli .... CRt: __ III....,.. {Of aIcuIMionl'. 
/ 
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thelial damage and subendothelial collection of lymphocytes. Immunohistochem-
ical staining showed T-cell infiltration with both CD4 and CD8 positive cells. In 
addition, there was expression of DR antigens on biliary and vascular epithelium, 
consistent with rejection {26]. Cells grown from this sample (LB9.9A) demon-
strated marked proliferation in three of four B 18 positive panel cells. No other 
donor specificity could be detected in all ten B 18 negative cells which shared 
other donor-specific antigens (Figure 3). 
The second donor was typed as A2,24; B7,49: DR2,4. Again, after initial 
function, deterioration of liver function occurred. A percutaneous liver biopsy 
(LB9.11 B) was done 11 days after the second transplant revealed severe choles-
tasis with moderate portal lymphocyte infiltration and evidence of bile duct injury. 
T cells were expanded from this biopsy and as shown in Table 6; allospecificity 
was determined to be against DR4 and possibly B7. Nine of the nine stimulator 
cells bearing these antigens induced proliferation of the biopsy cultured T cells 
in PLT. None of the five DR4 or 87 negative cells induced proliferation in this 
cell line. We found only slight PLT reactivity ofLB9.11B cells towards cells from 
the first transplant donor (donor A). 
Finally. after 39 days following the second transplant, in spite of~igorous 
efforts to reverse rejection. another allograft hepatectomy with retransplantation 
was required for iotractible rejection. as verified by histology. Cells grown from 
this sample (LB9.39B) were tested in PLT and revealed a similar pattern to cells 
obtained 4 weeks earlier. although a broader reactivinr pattern was noted from 
the latter liver sample (Table 6). 
Monoclonal Antibody Inhibition Profiles in PL T 
A panel of defined monoclonal anti-HLA antibodies were used to inhibit prolif-
eration of cultured biopsy lymphocytes towards irradiated donor stimulator cells. 
As shown in Table 7, the alIoreactivity of the biopsy-cultured cells, as determined 
by immunogenetic: analysis, was verified by blocking experiments w~th these 
MoAbs. Additiooof the class I specific MoAb. P A2.6, to cells grown from LB 1. 78 
fIGURE 3 PLT specificity of LB9.9A. Legend is the same as for Fisure 2. The back-
ground count was 222 :t 23 (1 SO). 
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TABLE 6 PLT reactivity of liver biopsies from patient #9 (second graft) 
HLA cypc 
,- -,- LB9.l1B LB 9.39B 
A A B 8 Oil DR (CPM) (CPM) 
~ 24- 7- 49" :l- 4- ~ NO 
25 13 44 4 ~ Qli 
2 18 27 6 4 ~ 28.705 
2 44 60 5 4 48.165 NO 
1 58 55 7 4 ~ NO 
2 3 35 5 4 ~ ~ 
29 31 7 60 7 4 12.,78 21.070 
2 29 7 8 4 NO ~ 
2 11 7 44 2 7 1'.116 n.!iQ 
2 1 7 62 3 7 8.414 lJ2l 
2 28 7 44 2 4 NO 1.537 
3 24 7 35 6 7 NO 756 
2 24 35 62 6 7 NO ~ 
2 11 44 51 2 8 NO ~ 
26' 11' 18' 41' r 5' 1M2 21.(Ml 
2 57 6 7 4.185 NO 
1 8 57 7 3.405 NO 
2 3 62 35 5 2.756 NO 
24 29 44 35 5 7 2.000 NO 
3 24 18 35 5 4.620 NO 
"Se<oad doacw. 
'F"anr doacw. 
Bcx'h inc -' I«ODcI c'- poIiIift ICiaIuIMon _ -'cdiDecI. 
(with PLT specificity towards class I donor antigens) resulted in. 51.7% reduction 
of.dooor-stimulated proliferation. In conuut. none of the class II specific MoAbs 
sigoificandy inhibited LBl.7B proliferation. 
The fine degree of disc:rimioarion of these MoAbs was also evident in the 
: inhibition profiles of LB7.5A and LB13.28B, both of which demonstrated class 
IlrelCtivity by PLT analysis. Cultured ceUs from both biopsies were not inhibited 
by P A2.6, while sipificant inhibition of prolifenrion was observed with the class 
II specific MoAhs. 
TABLE 7 Monoclonal antibody inhibition profiles of the cultured cells 
~ 
ClaM I CIua II 
Biopsy ceUs PAl.6 SGl57 SG465 1.243 Leu 10 
LBl.7B 51.7 NO -10.2 6 -6 
LB7.5A 8.3 64.1 62.9 33 42.2 
LBB.28B -9.3 74.5 43.3 49.1 18.5 
.. 
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Donor-Specific T-Cell Mediated Cytotoxicity 
In several instances, CML assays were used to assess the ability of..expanded 
biopsy-cultured T cells to lyse donor targets. Using PHA transformed T lympho-
blasts and/or E8V-transformed 8 Iymphoblastoid cell lines (derived from original 
donor spleen cells) as targets, cytotoxcity was determined at a 10: 1 effector/target 
ratio. As shown in Table 4, several T-cell lines demonstrated significant cytO-
toxicity towards donor specificities. In general, those lines showing significant 
cytotoxicity in this assay correlated to class I antigen induced proliferation in 
PLT assays. 
In patient M.S., LB 13.288, in vitro expanded intragraft T cells demonstrated 
DR3 allospecificiry in PLT assay. The recipient was HLA typed as Al,24; B35,w55; 
0R2.5 while the donor typed as Al.2; B51.8; OR3,7. CML assay showed 21% 
cytolysis of mY-transformed donor cells which correlated with CML specificity 
against the DR3 antigen. There was a much lower level of lympholysis against 
the PHA-transformed donor lymphoblast line (8%) and a significant lympholysis 
(32%) against another OR3 positive lymphoblastoid cell line (Figure 4). There-
fore, while the general rule that class I antigens serve as targets for cell mediated 
lympholysis, class II antigens can also serve as recognition structures for cell-
mediated lympholysis [41,42]. 
DISCUSSION 
We describe methodologies based upon our previous' experiences allowing ex-
pansion and characterization of intragraft T-cell populations in hepatic allografts 
[23]. The rationale behind our approach is based on acquisition of lL-2 receptors 
FIGURE" CML specificity of 1.8 13.28B. Percent Iympholysis is determined by [he 
formula: 
If}£ I hi' (experimental - spontaneous) release 
7l'} ymp 0 YSIS - • x 100% . (Tnron-X total - spontaneous) release 
HLA amigens of the panel cells arc listed; those shared with the original donor are 
underlined. Lymphocytes incubarcd with PHA-M for" days prior to testing arc designated 
as PHA targets. EBV fargees are splenocytes that 'Were originally transformed with EBV. 
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EBV 
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:x: -' 
PHA 1.- !.35 ~KR 
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during activation [43], and the subsequent requirement ofIL-2 for further prop": 
agarion {44]. In order to minimize introducing new antigen specificiti~ we used 
only lecrio-free 11..-2 without feedcrceUs to isolate and expand "the' in61trating 
cell popularion. In two insances, these ceDs exhibited the same phenotypic makeup 
of cells obtained in situ. 
When the phenotypic makeup of these biopsy bulk cultured ccDs were com-
pared to me aUospeciDcity of these cells, there did not appear to be·. consistent 
pattern lelating the predominance of either C04 or CDS to me HLA class 1 or 
class II specificity. This may reflect two possibilicies, (i) that CD4 and CD8 positive 
ceDs are not restricted by HLA class I or class II antigens or (ii) that the cultuled 
T-cell line lepresena • mixture of ceDs and only • small subpopularion of the 
expanded ceDs are responsible for aUospecificicy. Generally CD4 aUoractive cells 
recognize class II anti&ens whereas CDS .uotaetive ceDs rec:ognize class I an-
tigens; however, exceptions have recendy been reponed [45-47]. On the other 
hand, we have preliminary daa., usina limitina dilution analysis of these ceDs, 
that democmrares dill • proportion of aaivMed T ceDs do nor proliferate to 
donor HLA antigens. This sugesa dill only • subpopulation of the toW biopsy-
cultuled ceDs recognize HLA determinantS. 
Kumick and co-workers. usina. similar approach, have reccndy reponed their 
results chanctaizina apaoded TeeDs from rejectina renal aUosraft from patients 
on azathioprine and prednisone immunosuppression (22]. Phenotypic analysis 
of their ceU lines showed • predominance of cells bearing the CDS phenotype, 
although they also noced that in one patient treated with cyciosporine, that the 
CD4 and CDS populations were almost equal. The differences in the immuno-
suppression regimens may indeed explain the more frequent expression of CD4 
populations in our series, and has been noted in other human allograft models 
[26,48,49]. 
We have shown, by immUQOSeDCtic analysis. that both class I and class II HLA 
determinants can sene as recopition anrisens- In several instances, diese PLT 
findings were vcri6cd by monoclonal anti-HLA antibody inhibicioo profiles. In 
our preYious studies with aIIoreaaive T -cen clones (32], we have shown that 
both prolifenrive and cytotoXicicy assays can define allospecificicy to either class 
1 or class II antisens and COrlelaled well with monoclonal anti-HLA antibody 
inhibition profiles. Pmliferaciw: responses to class 1 antigens. where the donor 
and recipient are DR identical, were noted by Mayer et a1. {22]. In addition, we 
; plesent evideoce sugesrlna chat the same HLA antigenic determinant can serve 
as the recopition suuaure for both proliferarion and cyrolysis. This has been 
confirmed in Yiuo MIll senenred cloaed T-ceU lines (43]. 
Analysis of in sim senenred alIospecific: T -ceD lines from the initial and lub-
sequent allosnfa during rejection has shown that allorecopirion and infiltration 
of T ~eas is specific: and dynamic ill D&CUre. We have shown dw thele may be 
acquisiaoa of additioaal an ... lpeci6cicies duriD8 unsuccessful ueaanent of 
rejection. This is in apeemeDC with the obiervaUons on acquisition and loss of 
donor speci6c:ities in our preWxas repGm ltudyina hem aUosnfts {23]. Follow-
ins heparectOaly of die initial snfc containina cells with specificity towards the 
fint doaor. subsequear aUoarafa appear to have an influx of cells bearing spec-
ificity towards the donor antiaens of that respective sraft. Lare in lejection, 
however, nonspecific: mecb'nisml may aana "irrelevant" ceDs (7]. 
It is interatina to speculate on the role and ancisen specificicy of culture 
expanded incngraft T ceDs that do DOl: proliferate to donor HLA antisens nor 
lyse appropriare targets bearina donor HLA antiaens. 'The finding that non-HLA 
alloantigens, e.g., tissuMpedfic (50] and vacuIat endcxhelial cell or VEe [RM-~Oz 
antigens, can panicipae in allograft rejection, has been detDOnsttated. Unlike 
/ 
/ 
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the HLA system, definition of the majority of these non-HLA have been elusive, 
so that their imponance in allograft rejection is not clearcut. Nevertheless, once 
appropriate donor cell preparations can be obtained bearing the antigen system 
in question, application of the techniques described in this paper can begin to 
shed light on their relative role in allorecognition. 
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